“Navigating the evolving landscape of cancer treatment: a triad of progress” Andreas Pircher editorial 06 February 2024 Pages: 1 - 1
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer Eva Valentina Klocker short review Open access 19 December 2023 Pages: 6 - 9
(Neo)adjuvant approaches in lung cancer—paving the road to a cure Romana WassMaximilian HochmairBernd Lamprecht short review Open access 19 January 2024 Pages: 10 - 14
Total neoadjuvant therapy for each locally advanced rectal cancer? Gudrun Piringer short review Open access 28 December 2023 Pages: 15 - 19
Innovative therapeutic concepts for biliary tumors Angela Djanani short review Open access 29 January 2024 Pages: 20 - 25
Molecular typing—new targets and therapy options for upper GI carcinomas with a focus on adenocarcinomas of the esophagus, gastroesophageal junction, and stomach Katja Schmitz short review 05 January 2024 Pages: 26 - 29
Cancer of unknown primary—state of the art Thorsten Fuereder short review Open access 05 December 2023 Pages: 30 - 34
Management of oligometastatic prostate cancer Marcin MiszczykAleksander SlusarczykPaweł Rajwa short review 18 December 2023 Pages: 35 - 39
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review Stephan BrönimannNirmish SinglaShahrokh F Shariat short review Open access 16 January 2024 Pages: 40 - 44
Metastasis-directed therapy: new standard or too early to change paradigm? Jakob KlemmPawel RajwaShahrokh F. Shariat short review Open access 29 December 2023 Pages: 45 - 50
Genetic testing and management of prostate cancer patients with pathogenic germline variants Katharina ReiterMelanie R. Hassler short review Open access 03 November 2023 Pages: 51 - 56
Renal crystal-storing histiocytosis successfully treated with bortezomib-based regimen Poornima TadkalSiddini VishwanathMallikarjun Kalashetty case report 07 November 2023 Pages: 57 - 62
Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer Julia M. BergerPia GattingerMatthias Preusser special report Open access 13 October 2023 Pages: 63 - 66
Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule Theresa LentnerGerhard Krajnik case report Open access 23 January 2024 Pages: 67 - 70